Evaluation of the clinical effect of an artificial intelligence-assisted diagnosis and treatment system for neonatal seizures in the real world: a multicenter clinical study protocol
XIAO Tian-Tian, DOU Ya-Lan, ZHUANG De-Yi, HU Xu-Hong, KANG Wen-Qing, GUO Lin, ZHAO Xiao-Fen, ZHANG Peng, YAN Kai, YAN Wei-Li, CHENG Guo-Qiang, ZHOU Wen-Hao
Department of Neonatology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201101, China
Abstract Neonatal seizures are the most common clinical manifestations of critically ill neonates and often suggest serious diseases and complicated etiologies. The precise diagnosis of this disease can optimize the use of anti-seizure medication, reduce hospital costs, and improve the long-term neurodevelopmental outcomes. Currently, a few artificial intelligence-assisted diagnosis and treatment systems have been developed for neonatal seizures, but there is still a lack of high-level evidence for the diagnosis and treatment value in the real world. Based on an artificial intelligence-assisted diagnosis and treatment systems that has been developed for neonatal seizures, this study plans to recruit 370 neonates at a high risk of seizures from 6 neonatal intensive care units (NICUs) in China, in order to evaluate the effect of the system on the diagnosis, treatment, and prognosis of neonatal seizures in neonates with different gestational ages in the NICU. In this study, a diagnostic study protocol is used to evaluate the diagnostic value of the system, and a randomized parallel-controlled trial is designed to evaluate the effect of the system on the treatment and prognosis of neonates at a high risk of seizures. This multicenter prospective study will provide high-level evidence for the clinical application of artificial intelligence-assisted diagnosis and treatment systems for neonatal seizures in the real world.
XIAO Tian-Tian,DOU Ya-Lan,ZHUANG De-Yi et al. Evaluation of the clinical effect of an artificial intelligence-assisted diagnosis and treatment system for neonatal seizures in the real world: a multicenter clinical study protocol[J]. CJCP, 2022, 24(2): 197-203.
XIAO Tian-Tian,DOU Ya-Lan,ZHUANG De-Yi et al. Evaluation of the clinical effect of an artificial intelligence-assisted diagnosis and treatment system for neonatal seizures in the real world: a multicenter clinical study protocol[J]. CJCP, 2022, 24(2): 197-203.
Pisani F, Facini C, Bianchi E, et al. Incidence of neonatal seizures, perinatal risk factors for epilepsy and mortality after neonatal seizures in the province of Parma, Italy[J]. Epilepsia, 2018, 59(9): 1764-1773. PMID: 30132843. DOI: 10.1111/epi.14537.
Rennie JM, de Vries LS, Blennow M, et al. Characterisation of neonatal seizures and their treatment using continuous EEG monitoring: a multicentre experience[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(5): F493-F501. PMID: 30472660. PMCID: PMC6788873. DOI: 10.1136/archdischild-2018-315624.
Pressler RM, Cilio MR, Mizrahi EM, et al. The ILAE classification of seizures and the epilepsies: modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures[J]. Epilepsia, 2021, 62(3): 615-628. PMID: 33522601. DOI: 10.1111/epi.16815.
Shellhaas RA, Chang T, Tsuchida T, et al. The American Clinical Neurophysiology Society's guideline on continuous electroencephalography monitoring in neonates[J]. J Clin Neurophysiol, 2011, 28(6): 611-617. PMID: 22146359. DOI: 10.1097/WNP.0b013e31823e96d7.
Hoodbhoy Z, Masroor Jeelani S, Aziz A, et al. Machine learning for child and adolescent health: a systematic review[J]. Pediatrics, 2021, 147(1): e2020011833. PMID: 33323492. DOI: 10.1542/peds.2020-011833.
Greene BR, Faul S, Marnane WP, et al. A comparison of quantitative EEG features for neonatal seizure detection[J]. Clin Neurophysiol, 2008, 119(6): 1248-1261. PMID: 18381249. DOI: 10.1016/j.clinph.2008.02.001.
